Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Clin Endocrinol (Oxf). 2020 Sep;93(3):329-338. doi: 10.1111/cen.14147. Epub 2020 Jan 22.
Abnormal thyroid function in pregnant women is a matter of concern. Knowledge on the occurrence of known and unidentified thyroid function abnormalities in a large unselected cohort of pregnant women is warranted as part of the debate on benefits and risks of routine testing.
Cohort study.
A total of 14 323 pregnant women in the North Denmark Region, who had a blood sample drawn as part of the prenatal screening program in early pregnancy (2011-2015).
TSH, free thyroxine, thyroid peroxidase and thyroglobulin antibodies were measured in the stored blood samples using an automatic immunoassay (ADVIA Centaur XPT, Siemens Healthineers). Cohort-, method- and week-specific reference ranges were used for classification of maternal thyroid function, and a cut-off of 60 U/mL was used for thyroid autoantibodies. Information in Danish nationwide registers was used to identify diagnosed and treated maternal thyroid disease.
Overall, 15.2% had thyroid function abnormalities in the early pregnancy and 14.9% were thyroid peroxidase and/or thyroglobulin antibody positive. Among women with known thyroid disease (n = 365), the frequency of abnormal thyroid function was 45.7%, and 62.8% in women (n = 172) who received current treatment in the pregnancy. When maternal thyroid disease was diagnosed in the years following pregnancy (n = 313), 46.7% had abnormal thyroid function and 54.3% were thyroid peroxidase and/or thyroglobulin antibody positive in the early pregnancy.
Thyroid function abnormalities and thyroid autoantibodies were common in Danish pregnant women, particularly in women with known or later diagnosed thyroid disease, which raises concern about inadequately treated and unidentified abnormal thyroid function.
孕妇甲状腺功能异常是一个值得关注的问题。了解大量未经选择的孕妇中已知和未识别的甲状腺功能异常的发生情况,是对常规检测的益处和风险进行辩论的一部分。
队列研究。
丹麦北日德兰地区共有 14323 名孕妇,她们在孕早期(2011-2015 年)作为产前筛查计划的一部分抽取了血样。
使用自动免疫分析(ADVIA Centaur XPT,西门子健康)测量存储的血样中的 TSH、游离甲状腺素、甲状腺过氧化物酶和甲状腺球蛋白抗体。使用队列、方法和周特异性参考范围对母体甲状腺功能进行分类,甲状腺自身抗体的截断值为 60U/mL。丹麦全国登记册中的信息用于识别诊断和治疗的母体甲状腺疾病。
总体而言,15.2%的孕妇在孕早期甲状腺功能异常,14.9%的孕妇甲状腺过氧化物酶和/或甲状腺球蛋白抗体阳性。在已知患有甲状腺疾病的妇女(n=365)中,甲状腺功能异常的频率为 45.7%,在怀孕期间接受当前治疗的妇女(n=172)中为 62.8%。在产后几年诊断出母体甲状腺疾病的妇女(n=313)中,46.7%的孕妇甲状腺功能异常,在孕早期有 54.3%的孕妇甲状腺过氧化物酶和/或甲状腺球蛋白抗体阳性。
丹麦孕妇甲状腺功能异常和甲状腺自身抗体很常见,尤其是在已知或以后诊断为甲状腺疾病的妇女中,这引起了人们对治疗不足和未识别的异常甲状腺功能的关注。